Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

antimony/diarré

Länken sparas på Urklipp
13 resultat

Antimony toxicity from the use of tartar emetic for the treatment of alcohol abuse.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Antimony is a poisonous element with toxic properties that mimic those of arsenic. Numerous reports describe gastrointestinal complications of vomiting, diarrhea and stomatitis associated with antimony exposure. However, antimony toxicity from the use of tartar emetic as a treatment for alcohol

The exposure to and health effects of antimony.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND This minireview describes the health effects of antimony exposure in the workplace and the environment. OBJECTIVE To collate information on the consequences of occupational and environmental exposure to antimony on physiological function and well-being. METHODS The criteria used in the

Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Visceral leishmaniasis (kala-azar) affecting HIV-infected patient is being reported in increasing frequency. A 40-year-old German bisexual patient with full-blown AIDS is described who presented with Kaposi's sarcoma, epigastric pain, diarrhea, and weight loss but without fever. Leishmania

Phase IV trial of miltefosine in adults and children for treatment of visceral leishmaniasis (kala-azar) in Bangladesh.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Miltefosine (target dose of 2.5 mg/kg/day for 28 days) is the recommended treatment for visceral leishmaniasis (kala-azar) in Bangladesh on the basis of data from India. We evaluated miltefosine in a phase IV trial of 977 patients in Bangladesh. At the six-month final follow up, 701 were cured. 24

Management of visceral leishmaniasis: Indian perspective.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Diagnosis and treatment of Indian visceral leishmaniasis (VL) is extremely unsatisfactory. For diagnosis, demonstration of parasites in splenic/marrow smears remains the gold standard, though k39 rapid strip test is a useful method in regions where access to parasite demonstration is difficult.

Hepatitis C and B virus in schistosomiasis patients on oral or parenteral treatment.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Egypt leads the world in hepatitis C infection cases. Schistosomiasis and hepatitis C virus (HCV) co-infection is common in Egypt. Hepatitis B (HBsAg) is also encountered. Potassium antimony tartarate was used for schistosomiasis in endemic areas all over the world for more than 50 years,

Case study of a patient with HIV-AIDS and visceral leishmaniasis co-infection in multiple episodes.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Report of a 45-year-old male farmer, a resident in the forest zone of Pernambuco, who was diagnosed with human immunodeficiency virus (HIV) in 1999 and treated using antiretroviral (ARV) drugs. In 2005, the first episode of visceral leishmaniasis (VL), as assessed by parasitological diagnosis of
The pharmacokinetics and toxicities of free sodium stibogluconate (SSG) and two vesicular formulations of this drug (a nonionic surfactant vesicular formulation of SSG [SSG-NIV] and SSG-NIV-dextran) were determined after treatment with a single intravenous dose in healthy dogs and were related to

The concentrations of arsenic and other toxic elements in Bangladesh's drinking water.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
For drinking water, the people of Bangladesh used to rely on surface water, which was often contaminated with bacteria causing diarrhea, cholera, typhoid, and other life-threatening diseases. To reduce the incidences of these diseases, millions of tubewells were installed in Bangladesh since

Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Investigations of schistosomiasis mansoni in 218 Yemeni agricultural workers in the San Joaquin Valley of California revealed a prevalence of 56%. In those infected, quantitative egg counts performed by the Kato thick smear method revealed that 57% had light infections (1-100 eggs/g), 27% moderate

Is Visceral Leishmaniasis the same in HIV-coinfected adults?

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND Visceral Leishmaniasis is the most severe form of disease caused by the Leishmania donovani complex, with significant morbidity and mortality in developing countries. Worse outcomes occur among HIV-positive individuals coinfected with Leishmania. It is unclear, however, if there are
Miltefosine has been used in the treatment of several new world cutaneous leishmaniasis (CL) species with variable efficacy. Our study is the first evidence on its clinical efficacy in Leishmania (Viannia) guyanensis. In this phase II/III randomized clinical trial, 90 CL patients were randomly

Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
There is no recognized oral treatment for American cutaneous leishmaniasis. A rising-dose, open-label phase I/II trial of the oral agent miltefosine against Colombian cutaneous leishmaniasis was conducted. Seventy-two male Colombian soldiers (mean weight, 67 kg) received miltefosine at 50-100 mg/day
Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge